Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Oncolytic Virotherapy|December 13, 2018
Development and applications of oncolytic Maraba virus vaccinesJonathan G Pol, Matthew J Atherton, Byram W Bridle, et al.
Cancer Immunology Research|September 16, 2017
Customized Viral Immunotherapy for HPV-Associated CancerMatthew J Atherton, Kyle B Stephenson, Jonathan Pol, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 26, 2018
Diagnostic accuracy of leptospirosis whole-cell lateral flow assays: a systematic review and meta-analysisM J Maze, K J Sharples, K J Allan, et al.
Cancer Immunology Research|February 5, 2017
NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular VaccineAlmohanad A Alkayyal, Lee-Hwa Tai, Michael A Kennedy, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2008
Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysisThi Lien-Anh Nguyên, Hesham Abdelbary, Meztli Arguello, et al.
Molecular Therapy Oncolytics|December 3, 2016
Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodiesLaura Evgin, Carolina S Ilkow, Marie-Claude Bourgeois-Daigneault, et al.
Oncoimmunology|June 15, 2018
Transforming the prostatic tumor microenvironment with oncolytic virotherapyMatthew J Atherton, Kyle B Stephenson, Fanny Tzelepis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2014
Maraba MG1 virus enhances natural killer cell function via conventional dendritic cells to reduce postoperative metastatic diseaseJiqing Zhang, Lee-Hwa Tai, Carolina S Ilkow, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 5, 2012
Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccineChantal G Lemay, Julia L Rintoul, Agnieszka Kus, et al.
Pageof 4